New AI Tech Predicts Diagnostic Concordance For Melanoma, Proscia Says
Proscia released study results on new AI that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
Read MorePosted by Andy Lundin | Nov 1, 2022 | Melanoma |
Proscia released study results on new AI that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
Read MorePosted by Chris Wolski | Oct 27, 2022 | Digital Pathology |
Digital innovations are shifting the role of laboratory medicine and represent a new paradigm in standard of care.
Read MorePosted by Andy Lundin | Oct 24, 2022 | Emerging & Zoonotic Diseases |
GlycoPath’s proprietary technology was used to distinguish between Lyme disease infection states and track treatment response.
Read MorePosted by Andy Lundin | Oct 24, 2022 | Infectious Diseases |
The U.S. CDC states that antibiotic resistant infections are responsible for killing over a million people worldwide every year.
Read MorePosted by Chris Wolski | Oct 21, 2022 | Diagnostic Technologies |
Scientists developing a diagnostic tool that would use AI to speed the process of detecting biomarkers in biofluids have shown it could work.
Read More